Answer
Women of childbearing potential should use effective contraception during elotuzumab treatment and for 120 days following treatment, and must also follow the pregnancy prevention programme for lenalidomide or pomalidomide when used in combination.
Sources for this answer
- Empliciti 300 mg and 400 mg powder for concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked